SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-15-002092
Filing Date
2015-11-04
Accepted
2015-11-04 15:11:23
Documents
2
Period of Report
2015-11-02

Document Format Files

Seq Description Document Type Size
1 FORM 6-K transitionthera6k.htm 6-K 10869
2 NEWS RELEASE DATED NOVEMBER 2, 2015 ex991.htm EX-99.1 4834
  Complete submission text file 0001279569-15-002092.txt   16707
Mailing Address 101 COLLEGE STREET SUITE 220 TORONTO A6 M5G 1L7
Business Address 101 COLLEGE STREET SUITE 220 TORONTO A6 M5G 1L7 416-260-7770
Transition Therapeutics Inc. (Filer) CIK: 0001399250 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-33514 | Film No.: 151196669
SIC: 2833 Medicinal Chemicals & Botanical Products